Range Low Price High Price Comment
30 days $5.91 $5.91 Wednesday, 17th Aug 2022 EDGE stock ended at $5.91. During the day the stock fluctuated 0% from a day low at $5.91 to a day high of $5.91.
90 days $5.91 $5.91
52 weeks $4.60 $17.85

Historical Edge Therapeutics prices

Date Open High Low Close Volume
2022-03-24 $5.91 $5.91 $5.91 $5.91 0
2022-03-23 $5.91 $5.91 $5.91 $5.91 0
2022-03-22 $5.91 $5.91 $5.91 $5.91 0
2022-03-21 $5.91 $5.91 $5.91 $5.91 0
2022-03-18 $5.91 $5.91 $5.91 $5.91 0
2022-03-17 $5.91 $5.91 $5.91 $5.91 0
2022-03-16 $5.91 $5.91 $5.91 $5.91 0
2022-03-15 $5.91 $5.91 $5.91 $5.91 0
2022-03-14 $5.91 $5.91 $5.91 $5.91 0
2022-03-11 $5.91 $5.91 $5.91 $5.91 0
2022-03-10 $5.91 $5.91 $5.91 $5.91 0
2022-03-09 $5.91 $5.91 $5.91 $5.91 0
2022-03-08 $5.91 $5.91 $5.91 $5.91 0
2022-03-07 $5.91 $5.91 $5.91 $5.91 0
2022-03-04 $5.91 $5.91 $5.91 $5.91 0
2022-03-03 $5.91 $5.91 $5.91 $5.91 0
2022-03-02 $5.91 $5.91 $5.91 $5.91 0
2022-03-01 $5.95 $6.17 $5.85 $5.91 170 157
2022-02-28 $5.91 $6.16 $5.91 $5.98 352 800
2022-02-25 $6.06 $6.14 $5.82 $6.01 226 872
2022-02-24 $5.29 $6.07 $4.96 $6.00 506 768
2022-02-23 $6.01 $6.28 $5.66 $5.69 585 415
2022-02-22 $6.12 $6.36 $5.76 $5.87 393 472
2022-02-18 $6.72 $6.82 $6.19 $6.20 364 825
2022-02-17 $7.16 $7.26 $6.61 $6.64 298 530
Click to get the best stock tips daily for free!

About Edge Therapeutics

Edge Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and commercializes hospital-based therapies for acute life-threatening neurological conditions. Its lead product includes EG-1962, a polymer-based microparticle used for the treatment of aneurysmal subarachnoid hemorrhage. The company also develops EG-1964 for the management of chronic subdural hematoma as a prophylactic treatment to prevent recurrent bleeding. ... EDGE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT